Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COG pilot study for very high risk acute lymphoblastic leukemia in children and adolescents
2012-001477-82Phase 3
- Sponsor
- Children's Oncology Group
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by Children's Oncology Group. Primary endpoint: Feasibility (toxicity and patient accrual).
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2012-001477-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001477-82.